Olive Tree People Inc., a subsidiary of Oliveda International, Inc., announced the first International Hydroxytyrosol Award. This award will be endowed with $100,000 each year to further international research into hydroxytyrosol and longevity research on olive trees.

Olive Tree People, a subsidiary of Oliveda International, Inc., announced 400% growth in the first quarter of 2025. The company saw an almost 1700% growth rate in its second year in the US, with sales of over $104.5 million.

Olive Tree People, a subsidiary of Oliveda International, Inc., announced its financial results for 2024. In its second year, the company reported a 1700% growth rate, with sales of $104.5 million.

Oliveda International, Inc. reported that its subsidiary Olive Tree People Inc. grew more than 1,000% in January 2025.

Thomas Lommel could never have foreseen the path that illness and burnout would lead him on. In the late 1990s—fighting both illness and the effects of strong medication—Thomas found himself searching for answers about his health, his way of life and which path could lead him out of his circumstances.

Olive Tree People Inc. announced record-breaking sales numbers. The subsidiary of Oliveda International, Inc. launched in the United States 21 months ago and exceeded the $2 million daily sales mark in September 2024.

Olive Tree People announced the launch of Olive Rose, a skin tint serum powered by hydroxytyrosol, an olive-leaf derived compound rich in antioxidants.

Oliveda International, Inc. announced Q3 2024 growth of 2,500% compared to Q3 2023. This is a 47% increase compared to Q2 2024 and a more than 580% increase compared to the first quarter of 2024.

Olive Tree People is building a waterless beauty movement. Eighteen months after its launch in the United States, the company, a subsidiary of Oliveda International, Inc., surpassed the $2 million in sales per day milestone.